Bill of Health

MARCH 24, 2023

The selections feature topics ranging from an analysis of the approval and marketing of biosimilars with a skinny label and their associated Medicare savings, to a discussion of the Philips Respironics recall and the need for reforms to U.S. Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D. N Engl J Med.

Medicare 144

Medicare Medicare Medicaid Medicaid 144

Healthcare Law Blog

AUGUST 3, 2022

Food and Drug Administration (“FDA”) recommendations, causing the providers to submit false claims for payment to Medicare for the services mis-using the probes. The complaint alleges that Prometheus put vulnerable Medicare patients at risk to gain a marketing advantage by reducing overhead costs associated with its systems.

Governance 52

Governance FDA Medicare Medicare 52

The Digital Health Corner

JUNE 14, 2017

According to most recent statistics from the Office of the National Coordinator, use of EHRs has increased from 20% in 2004 to 87% in 2015. I’d like to discuss what I believe are five areas of significant opportunity for quality technologies. EHRs were designed as documentation centers for billing and regulatory purposes.

Patient Satisfaction 87

Patient Satisfaction Hospitals FDA Governance 87

Hall Render

FEBRUARY 2, 2024

NATIONAL Amazon Pharmacy, One Medical pilot program integrates medication consultations Bad news for FTC’s noncompete ban Cigna to sell Medicare business to HCSC for $3.3B

Nursing Homes 40

Nursing Homes US Department of Health and Human Services Nurses Hospitals 40